TrialJournal of diabetes investigation2020

Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study.

Tomoe Kinoshita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.